Livagen

Overview

Livagen is a short peptide within the Khavinson family of organ-directed bioregulators developed by Vladimir Khavinson and colleagues. In that framework, each short peptide is associated with a specific tissue; Livagen is assigned to liver (hepatic) regulation. It is discussed in longevity and research communities primarily in the context of hepatic function, chromatin activity in lymphocytes, and as a member of the broader short-peptide bioregulator family.

A distinctive feature of Livagen in published Russian research is that it has been evaluated in chromatin decondensation assays, where short peptides are applied to lymphocytes from aged donors to examine whether they can influence heterochromatin structure. Reported findings in that system contributed to the Khavinson hypothesis that very short peptides can modulate gene accessibility.

Livagen is typically discussed alongside other Khavinson peptides: Pinealon, Cortagen, Vilon, Vesugen, and the longer pineal peptide Epitalon. Thymic research peptides Thymalin and Thymulin are often referenced in the same longevity context.

Structure / Chemistry

Livagen is commonly described as the tripeptide Lys-Glu-Asp (KED). As with other Khavinson short peptides, it is unmodified and typically supplied as the free acid.

Mechanism of Action

Proposed mechanisms center on modulation of gene expression — the Khavinson group has published on lymphocyte chromatin decondensation in aged donor cells after exposure to short peptides including Livagen. Broader hepatic effects proposed in the literature include influences on liver function markers and protection against experimental injury, though mechanistic specificity at the molecular level remains an area of ongoing research.

Research Summary

Pharmacokinetics

Publicly available pharmacokinetic data on Livagen in English-language literature are limited. Research-context administration is typically subcutaneous or intranasal, with short-peptide pharmacokinetics expected to involve rapid clearance but potential for tissue uptake.

Common Discussion Topics

• Chromatin decondensation findings and their interpretation.
• Tissue specificity claims within the Khavinson framework.
• Comparative role versus other liver-directed research strategies.
• Combination with other Khavinson peptides in longevity protocols.
• Reproducibility of findings in independent laboratories.

Related Compounds

• Pinealon
• Cortagen
• Vilon
• Vesugen
• Epitalon